Trial intelligence / Profile preview

Neuroscience of Marijuana Impaired Driving

NCT02757313Phase 1Completed

Sponsor
Yale University
Start
Oct 2016
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of cannabis, sponsored by Yale University. Primary endpoints: Change in performance on fMRI simulated driving Gap Acceptance Task at 5.25 hours and Change in performance on fMRI simulated driving Road Tracking Task at 5.25 hours. Started Oct 2016; status: completed.

02

Drugs

cannabis

Beyond the preview

Go deeper on NCT02757313.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02757313.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call